Incidence of renal replacement therapy (RRT) in the diabetic compared with the non-diabetic population in a German region, 2002-08

Nephrology Dialysis Transplantation

Volumn 26, Issue 1, 2011, Pages 264-269

  Icks, Andrea ^a   Haastert, Burkhard ^b   Genz, Jutta ^a   Giani, Guido ^a   Hoffmann, Falk ^c   Trapp, Rudolf ^d   Koch, Michael ^d,e  

^a HEINRICH HEINE UNIVERSITY   (Germany)

^b Heinrich Heine University Dsseldorf ^*  (Germany)

^c UNIVERSITY OF BREMEN   (Germany)

^d Center of Nephrology   (Germany)

^e Institute of Medical Sociology   (Germany)

Author keywords

diabetes; Germany; incidences, relative and attributable risks of RRT due to diabetes; population based study; renal replacement therapy (RRT)

Indexed keywords

ADULT; AGED; ARTICLE; CONTROLLED STUDY; DIABETES MELLITUS; DIABETIC PATIENT; FEMALE; GERMANY; HEMODIALYSIS; HUMAN; INCIDENCE; KIDNEY FAILURE; MAJOR CLINICAL STUDY; MALE; PREVALENCE; PRIORITY JOURNAL; RENAL REPLACEMENT THERAPY;

ADULT; AGED; AGED, 80 AND OVER; DIABETES COMPLICATIONS; DIABETES MELLITUS; FEMALE; GERMANY; HUMANS; INCIDENCE; KIDNEY FAILURE, CHRONIC; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; REGISTRIES; RENAL DIALYSIS; RENAL REPLACEMENT THERAPY; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 78650649993     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gfq398     Document Type: Article

References (35)

1. Bash LD, Astor BC, Coresh J. Risk of incident ESRD: a comprehensive look at cardiovascular risk factors and 17 years of follow-up in the ARIC study. Am J Kidney Dis 2010; 55: 31-41
2. Boddana P, Caskey F, Casula A et al. UK renal registry 11th annual report (December 2008): chapter 14 UK renal registry and international comparisons. Nephron Clin Pract 2009; 111: c269-c276
3. Dirks JH, De Zeeuw D, Agarwal SK et al. Prevention of chronic kidney and vascular disease: toward global health equity-the Bellagio 2004 Declaration. Kidney Int 2005; 68: S1-S6
4. Hamer RA, Meguid Ek Nahas A. The burden of chronic kidney disease. BMJ 2006; 332: 563-564
5. Hsu CY, Iribarren C, McCulloch CE et al. Risk factors for end-stage renal disease: 25 year follow-up. Arch Intern Med 2009; 169: 342-350
6. Koch M, Thomas B, Tschöpe Wet al. Survival and predictors of death in dialysed diabetic patients. Diabetologia 1993; 36: 1113-1117
7. Köster I, von Ferber L, Ihle P et al. The cost burden of diabetes melli-tus: the evidence from Germany-the CoDiM Study. Diabetologia 2006; 9: 1498-1504
8. Muntner P, Coresh J, Powe NR et al. The contribution of increased diabetes prevalence and improved myocardial infarction and stroke survival to the increase in treated end-stage renal disease. J Am Soc Nephrol 2003; 14: 1568-1577
9. Roblin DW, Khoury A, Pisanelli W et al. Risk for incident renal dialysis in a managed care population. Am J Kidney Dis 2006; 48: 205-211
10. Schieppati A, Remuzzi G. Chronic renal diseases as a public health problem: epidemiological, social, and economic implications. Kidney Int 2005; 68: S7-S10
11. Brancati FL, Whelton PK, Randall BL et al. Risk of end-stage renal disease in diabetes mellitus: a prospective cohort study of men screened for MRFIT. Multiple Risk Factor Intervention Trial. JAMA 1997; 278: 1069-1074
12. Diabetes care and research in Europe. The Saint Vincent Declaration. World Health Organization, ICP/CLR 034, 1989
13. Bundesversicherungsamt. Disease Management Program (DMP) Diabetes mellitus. http://www.bundesversicherungsamt.de/cln-091/ nn-1046648/DE/DMP/dmp- node.html?-nnn=true (17 December 2008, date last accessed).
14. Icks A, Dickhaus T, Hörmann A et al. Lower incidence of myocardial infarction in non-diabetic subjects and in diabetic women, but not in diabetic men, in the population aged 25 to 74 years. Findings from the MONICA/KORA myocardial infarction registry in Southern Germany, 1985-2006. Diabetologia 2009; 52: 1836-1841.
15. Icks A, Haastert B, Trautner C et al. Incidence of lower-limb amputations in the diabetic compared to the non-diabetic population. Findings from nationwide insurance data, Germany, 2005-2007. Exp Clin Endocrinol Diabetes 2009; 117: 500-504
16. Ratzmann K. Erkenntnisse aus der Epidemiologie. Akt Ernähr Med 1992; 17: 55-56
17. Meisinger C, Heier M, Doering A et al. Prevalence of known diabetes and antidiabetic therapy between 1984/1985 and 2000/2001 in Southern Germany. Diabetologia 2004; 27: 2985-2987
18. Icks A, Moebus S, Feuersenger A et al. Diabetes prevalence and association with social status-widening of a social gradient? German national health surveys 1990-92 and 1998. Diabetes Res Clin Pract 2007; 78: 293-297
19. Trautner C, Icks A, Haastert B et al. Incidence of blindness in relation to diabetes. A population-based study. Diabetes Care 1997; 20: 1147-1153
20. TrautnerC,Haastert B, GianiGetal. Incidenceofblindnessinsouthern Germany between 1990 and 1998. Diabetologia 2001; 44: 147-150
21. Trautner C, Haastert B, Mauckner P et al. Reduced incidence of lower-limb amputations in the diabetic population of a German city, 1990-2005. Results of the Leverkusen Amputation Reduction Study (LARS). Diabetes Care 2007; 30: 2633-2637.
22. WHO/IDF (World Health Organization/International Diabetes Federation). Definition and Diagnosis of Diabetes Mellitus and Intermediate Hyperglycemia: Report of a WHO/IDF Consultation. Geneva, Switzerland: World Health Organization, 2006.
23. Frei U, Schober-Halstenberg HJ. Nierenersatztherapie in Deutschland. Bericht 2005/2006. QuaSi Niere 2006
24. United States Renal Data System. http://www.usrds.org/qtr/qrt- report-table-c-Q1-09.html (23 March 2010, date last accessed)
25. Rothman K, Greenland S. Modern Epidemiology. 2nd edn. Philadelphia: Lippincoll-Raven, 2008
26. Le CT. Introductory Biostatistics. Weinheim: Wiley, 2003
27. Drey N, Roderick P, Mullee M et al. A population-based study on the incidence and outcomes of chronic kidney disease. Am J Kidney Dis 2003; 42: 677-684
28. Burrows NR, Li Y, Geiss LS. Incidence of treatment for end-stage renal disease among individuals with diabetes in the US continues to decline. Diabetes Care 2009; 33: 73-77
29. Ritz E, Rychlik I, Locatelli F et al. End-stage renal failure in type 2 diabetes: a medical catastrophe of worldwide dimensions.Am J Kidney Dis 1999; 34: 795-808
30. Ritz E, Stefanski A. Diabetic nephropathy in type 2 diabetes. Am J Kidney Dis 1996; 27: 167-194
31. Icks A, Haastert B, Gandjour A et al. Costs of dialysis-a regional population-based analysis. Nephrol Dial Transplant 2009; 25: 1647-1652
32. Heidemann C, Kroll L, Icks A et al. Prevalence of known diabetes among German adults aged 25 to 69 years: results from national health surveys over 15 years. Diabet Med 2009; 26: 655-658
33. Rathmann W, Haastert B, Icks A et al. High prevalence of undiag-nosed diabetes mellitus in Southern Germany: target populations for effective screening. The KORA Survey 2000. Diabetologia 2003; 46: 190-194
34. Mutsert R, Jager KJ, Zoccali C et al. The effect of joint exposures: examining the presence of interaction. Kidney Int 2009; 75: 677-681
35. Jager DJ, Grootenhorst DC, Jager KJ et al. Cardiovascular and non-cardiovascular mortality among patients starting dialysis. JAMA 2009; 302: 1782-1789